Reconstitution of Human Thymic Implants Is Limited by Human Immunodeficiency Virus Breakthrough during Antiretroviral Therapy

Human immunodeficiency virus type 1 (HIV-1)-infected SCID-hu thymic implants depleted of CD4(+) cells can support renewed thymopoiesis derived from both endogenous and exogenous T-cell progenitors after combination antiretroviral therapy. However, successful production of new thymocytes occurs trans...

Full description

Saved in:
Bibliographic Details
Main Authors: Amado, Rafael G., Jamieson, Beth D., Cortado, Ruth, Cole, Steve W., Zack, Jerome A.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 1999
Subjects:
Pathogenesis and Immunity
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC112715/
https://ncbi.nlm.nih.gov/pubmed/10400728
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items